Form D Explorer

Form C-AR — Rejuve Biotech Inc.

0001669191-25-000296 · filed 2025-04-30

Offering

Target
Maximum
Security type
Price per security
Deadline
Oversubscription

Issuer

CIK
1994911
Entity
Corporation
Jurisdiction
DE
Address
982A N. BATAVIA STREET
ORANGE, CA 92867
Phone

Most recent fiscal year financials

Total assets
$257,811
Cash
Short-term debt
Long-term debt
Revenues
COGS
Taxes paid
Net income
$-13,513

View original on SEC EDGAR.